"/> Novus Biologicals™ Peptide bloquant d’anticorps EB… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps EBI3

Réf. : BL-RE-081073Réf. fabricant : 18268965 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
10148
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76976. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 15 amino acids near the carboxy terminus of human EBI3.

Points forts

Source

Synthetic

(Accession #: NP_005746) The EBI3 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-081073
Réf. fabricant18268965
Gene ID (Entrez)10148
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76976. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gènecytokine receptor, EBV-induced gene 3 protein, Epstein-Barr virus induced 3, Epstein-Barr virus induced gene 3, Epstein-Barr virus-induced gene 3 protein, IL-27 subunit beta, IL27B, IL-27 B, interleukin-27 subunit beta
Symbole de gène(s)EBI3
Type de produitIL-27/IL-35 EBI3 Subunit
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne15 amino acids near the carboxy terminus of human EBI3
Une question, une configuration particulière ?
Contactez-nous pour un devis.